Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.30 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
| ▸ | APAF1 | O14727 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MITF | O75030 | 1/20 | 0.30 |
| ▸ | NSD2 | O96028 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8591941 | 0.89 | CYP2C9 (0.32) | CYP2C9CYP2C19 | |
| SCHEMBL7802925 | 0.85 | CYP2C9 (0.33) | CYP2C9CYP2C19TDP1 | |
| SCHEMBL2196632 | 0.82 | PAOX (0.36) | PAOXALDH1A1SIGMAR1APAF1NPC1 | |
| SCHEMBL10506433 | 0.81 | TDP1 (0.39) | CYP2C9CYP2C19TDP1MAPT | |
| SCHEMBL8589615 | 0.81 | — | — | |
| SCHEMBL9746468 | 0.77 | CYP2C9 (0.46) | CYP2C9CYP2C19TDP1ALDH1A1 | |
| SCHEMBL6248960 | 0.77 | CYP2C9 (0.32) | CYP2C9CYP2C19 | |
| SCHEMBL6137087 | 0.76 | TDP1 (0.44) | CYP2C9CYP2C19TDP1 | |
| SCHEMBL9280225 | 0.74 | CYP2C19 (0.48) | CYP2C9CYP2C19TDP1ALDH1A1MAPT | |
| SCHEMBL4340553 | 0.73 | CYP2C9 (0.30) | CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1734079-B1 | SINGLE-COMPONENT CURABLE COMPOSITION | KANEKA CORP (JP) | 2016-01-20 | — | — | EP | disclosed |
| EP-1930375-B1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND ADHESIVENESS | KANEKA CORP (JP) | 2012-07-04 | — | — | EP | disclosed |
| EP-1942153-B1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND STORAGE STABILITY | KANEKA CORP (JP) | 2010-11-17 | — | — | EP | disclosed |
| EP-1942153-A1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND STORAGE STABILITY | Kaneka Corporation (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1930375-A1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND ADHESIVENESS | Kaneka Corporation (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-20080021140-A1 | Curable Composition | KANEKA CORPORATION (JP) | 2008-01-24 | — | — | US | disclosed |
| US-20070208108-A1 | Single-Component Curable Composition | KANEKA CORPORATION (JP) | 2007-09-06 | — | — | US | disclosed |
| US-20070203297-A1 | Curable Composition | KANEKA CORPORATION | 2007-08-30 | — | — | US | disclosed |
| EP-1736511-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-27 | — | — | EP | disclosed |
| EP-1734079-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | Kaneka Corporation (JP) | 2006-12-20 | — | — | EP | disclosed |
| EP-1731574-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| EP-1731573-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-5140068-A | Toughness, adhesion, elongation | THE B. F. GOODRICH COMPANY (US) | 1992-08-18 | — | — | US | disclosed |